Waltzer W C, Zincke H, Sterioff S, Offord K P, Frohnert P P
Surg Gynecol Obstet. 1981 Apr;152(4):476-82.
Renal transplantation in the nondiabetic patient can be achieved with a graft survival comparable with the over-all survival of the cadaveric first graft. The utilization of immunologic donor pretreatment in second cadaveric renal transplantation was of no benefit to graft survival. The second graft survived significantly longer than the first graft when the survival in the same patients was evaluated in a paired fashion. In our experience, retransplantation in the patient with juvenile-onset diabetes using a cadaveric graft gives disastrous results. Of pretreatment, splenectomy, transfusion, preformed antibodies, antigens mismatched, course and time of first-graft loss, diabetes, age and donor source analyzed in this study, only diabetes was found to have a significant effect upon the survival of the second graft.
非糖尿病患者的肾移植可实现移植物存活率与尸体首次移植的总体存活率相当。在第二次尸体肾移植中使用免疫供体预处理对移植物存活没有益处。当以配对方式评估同一患者的存活率时,第二次移植的移植物存活时间明显长于第一次移植的移植物。根据我们的经验,使用尸体移植物对青少年糖尿病患者进行再次移植会产生灾难性后果。在本研究中分析的预处理、脾切除术、输血、预先形成的抗体、抗原不匹配、首次移植物丢失的过程和时间、糖尿病、年龄和供体来源中,仅发现糖尿病对第二次移植物的存活有显著影响。